
zzso storage disease type I zzso is a group of zzso zzso disorders with an zzso of 1 in zzso The two major zzso are zzso zzso caused by a zzso of zzso zzso and zzso zzso caused by a zzso in the zzso zzso zzso Both zzso and zzso are associated with the zzso zzso zzso zzso zzso zzso zzso zzso from the zzso into the zzso of the zzso where zzso zzso the zzso into zzso and zzso Together zzso and zzso maintain zzso zzso zzso is expressed in zzso zzso the liver, zzso and zzso However zzso which zzso zzso efficiently only in the presence of zzso is expressed zzso This suggests that zzso may play other roles in zzso lacking zzso Both zzso and zzso patients manifest zzso zzso zzso characterized by growth zzso zzso zzso zzso zzso zzso and zzso academia and the current treatment is a dietary zzso zzso patients also suffer from chronic zzso and functional deficiencies of zzso and zzso which is treated with zzso colony stimulating factor to restore zzso zzso The zzso and zzso genes have been zzso To date, 76 zzso and 69 zzso zzso have been identified in zzso zzso A database of the residual zzso activity retained by the zzso zzso zzso is zzso the correlation of the disease zzso with the patients' zzso While the molecular basis for the zzso disorders are now known and symptomatic therapies are available, many aspects of the diseases are still poorly zzso and there are no zzso Recently developed animal models of the disorders are now being exploited to delineate the disease more precisely and develop new, more zzso zzso 

